April 3, 2020 09:55 AM EDT

GSK vaccine chief heads for AIDS vaccine initiative; Pfizer enlists Sue Desmond-Hellmann to its board of directors

ENDPOINTS

→ Rip Ballou, who until very recently led vaccine research and development at GlaxoSmithKline, is joining the International AIDS Vaccine …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

GSK vaccine chief heads for AIDS vaccine initiative; Pfizer enlists Sue Desmond-Hellmann to its board of directors

ENDPOINTS

Sign up to read this article for free.

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Regeneron plans to buy 23andMe for $256M

David Liu, Sam Sternberg unveil new way to insert big genes in human cells

Prime Medicine sidelines only clinical program, replaces CEO and lays off some staff

Exclusive: CellCentric collects $120M to treat multiple myeloma with a capsule

Intellia's CRISPR therapy likely causes 'permanent' gene knockdown in ATTR amyloidosis

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?

GSK vac­cine chief heads for AIDS vac­cine ini­tia­tive; Pfiz­er en­lists Sue Desmond-Hell­mann to its board of di­rec­tors

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

GSK vaccine chief heads for AIDS vaccine initiative; Pfizer enlists Sue Desmond-Hellmann to its board of directors